Cargando…

Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation

BACKGROUND: Spondyloarthritis (SpA) is an autoimmune and autoinflammatory musculoskeletal disease characterised by systemic enthesitis. Recent research has focused on subclinical inflammatory bowel disease (IBD) in SpA pathogenesis. SKG mice, harbouring the Zap70 W163C mutation, increase autoreactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabuchi, Yuya, Katsushima, Masao, Nishida, Yuri, Shirakashi, Mirei, Tsuji, Hideaki, Onizawa, Hideo, Kitagori, Koji, Akizuki, Shuji, Nakashima, Ran, Murakami, Kosaku, Murata, Koichi, Yoshifuji, Hajime, Tanaka, Masao, Morinobu, Akio, Hashimoto, Motomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310491/
https://www.ncbi.nlm.nih.gov/pubmed/35879738
http://dx.doi.org/10.1186/s13075-022-02844-4
_version_ 1784753395739918336
author Tabuchi, Yuya
Katsushima, Masao
Nishida, Yuri
Shirakashi, Mirei
Tsuji, Hideaki
Onizawa, Hideo
Kitagori, Koji
Akizuki, Shuji
Nakashima, Ran
Murakami, Kosaku
Murata, Koichi
Yoshifuji, Hajime
Tanaka, Masao
Morinobu, Akio
Hashimoto, Motomu
author_facet Tabuchi, Yuya
Katsushima, Masao
Nishida, Yuri
Shirakashi, Mirei
Tsuji, Hideaki
Onizawa, Hideo
Kitagori, Koji
Akizuki, Shuji
Nakashima, Ran
Murakami, Kosaku
Murata, Koichi
Yoshifuji, Hajime
Tanaka, Masao
Morinobu, Akio
Hashimoto, Motomu
author_sort Tabuchi, Yuya
collection PubMed
description BACKGROUND: Spondyloarthritis (SpA) is an autoimmune and autoinflammatory musculoskeletal disease characterised by systemic enthesitis. Recent research has focused on subclinical inflammatory bowel disease (IBD) in SpA pathogenesis. SKG mice, harbouring the Zap70 W163C mutation, increase autoreactive Th17 cells intrinsically, and in a conventional environment, they exhibit spontaneous arthritis with fungal factors. Under SPF conditions, they show SpA features, including enteritis, after peritoneal injection of β-1,3-glucan. This study aimed to clarify whether oral dextran sulfate sodium (DSS) administration, utilised in IBD model mice, can provoke SpA features in SKG mice under SPF conditions, focusing on the relationship between gut microorganisms and SpA pathogenesis. METHODS: BALB/c and SKG mice were administered oral DSS, and their body weights, arthritis, and enthesitis scores were recorded. In another cohort, antibiotics (meropenem and vancomycin) or an anti-fungal agent (amphotericin B) was administered orally before DSS administration. The splenic Th1 and Th17 cell populations were examined before and after DSS administration using flow cytometry. Furthermore, the amount of circulating bacterial DNA in whole blood was measured by absolute quantitative polymerase chain reaction (qPCR), and the number and characteristics of bacterial species corresponding to these circulating DNA were analysed by next-generation sequencing (NGS). RESULTS: Ankle enthesitis as a peripheral SpA feature was elicited in half of DSS-administered SKG mice, and none of the BALB/c mice. Pre-administration of antibiotics suppressed enthesitis, whilst an anti-fungal agent could not. Th1 and Th17 cell levels in the spleen increased after DSS administration, and this was suppressed by pre-administration of antibiotics. SKG mice have a larger amount of bacterial DNA in whole blood than BALB/c mice before and 1 day after the initiation of DSS administration. The number of bacterial species in whole blood increased after DSS administration in BALB/c and SKG mice. Some genera and species significantly specific to the DSS-treated SKG mouse group were also detected. CONCLUSION: Oral DSS administration alone elicited peripheral enthesitis in SKG mice with bacterial translocation accompanied by increased splenic Th1 and Th17 cell levels. Pre-administration of antibiotics ameliorated these DSS-induced SpA features. These findings suggest that intestinal bacterial leakage plays a pivotal role in SpA pathogenesis.
format Online
Article
Text
id pubmed-9310491
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93104912022-07-26 Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation Tabuchi, Yuya Katsushima, Masao Nishida, Yuri Shirakashi, Mirei Tsuji, Hideaki Onizawa, Hideo Kitagori, Koji Akizuki, Shuji Nakashima, Ran Murakami, Kosaku Murata, Koichi Yoshifuji, Hajime Tanaka, Masao Morinobu, Akio Hashimoto, Motomu Arthritis Res Ther Research BACKGROUND: Spondyloarthritis (SpA) is an autoimmune and autoinflammatory musculoskeletal disease characterised by systemic enthesitis. Recent research has focused on subclinical inflammatory bowel disease (IBD) in SpA pathogenesis. SKG mice, harbouring the Zap70 W163C mutation, increase autoreactive Th17 cells intrinsically, and in a conventional environment, they exhibit spontaneous arthritis with fungal factors. Under SPF conditions, they show SpA features, including enteritis, after peritoneal injection of β-1,3-glucan. This study aimed to clarify whether oral dextran sulfate sodium (DSS) administration, utilised in IBD model mice, can provoke SpA features in SKG mice under SPF conditions, focusing on the relationship between gut microorganisms and SpA pathogenesis. METHODS: BALB/c and SKG mice were administered oral DSS, and their body weights, arthritis, and enthesitis scores were recorded. In another cohort, antibiotics (meropenem and vancomycin) or an anti-fungal agent (amphotericin B) was administered orally before DSS administration. The splenic Th1 and Th17 cell populations were examined before and after DSS administration using flow cytometry. Furthermore, the amount of circulating bacterial DNA in whole blood was measured by absolute quantitative polymerase chain reaction (qPCR), and the number and characteristics of bacterial species corresponding to these circulating DNA were analysed by next-generation sequencing (NGS). RESULTS: Ankle enthesitis as a peripheral SpA feature was elicited in half of DSS-administered SKG mice, and none of the BALB/c mice. Pre-administration of antibiotics suppressed enthesitis, whilst an anti-fungal agent could not. Th1 and Th17 cell levels in the spleen increased after DSS administration, and this was suppressed by pre-administration of antibiotics. SKG mice have a larger amount of bacterial DNA in whole blood than BALB/c mice before and 1 day after the initiation of DSS administration. The number of bacterial species in whole blood increased after DSS administration in BALB/c and SKG mice. Some genera and species significantly specific to the DSS-treated SKG mouse group were also detected. CONCLUSION: Oral DSS administration alone elicited peripheral enthesitis in SKG mice with bacterial translocation accompanied by increased splenic Th1 and Th17 cell levels. Pre-administration of antibiotics ameliorated these DSS-induced SpA features. These findings suggest that intestinal bacterial leakage plays a pivotal role in SpA pathogenesis. BioMed Central 2022-07-25 2022 /pmc/articles/PMC9310491/ /pubmed/35879738 http://dx.doi.org/10.1186/s13075-022-02844-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tabuchi, Yuya
Katsushima, Masao
Nishida, Yuri
Shirakashi, Mirei
Tsuji, Hideaki
Onizawa, Hideo
Kitagori, Koji
Akizuki, Shuji
Nakashima, Ran
Murakami, Kosaku
Murata, Koichi
Yoshifuji, Hajime
Tanaka, Masao
Morinobu, Akio
Hashimoto, Motomu
Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title_full Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title_fullStr Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title_full_unstemmed Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title_short Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
title_sort oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in skg mice accompanied by intestinal bacterial translocation and systemic th1 and th17 cell activation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310491/
https://www.ncbi.nlm.nih.gov/pubmed/35879738
http://dx.doi.org/10.1186/s13075-022-02844-4
work_keys_str_mv AT tabuchiyuya oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT katsushimamasao oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT nishidayuri oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT shirakashimirei oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT tsujihideaki oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT onizawahideo oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT kitagorikoji oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT akizukishuji oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT nakashimaran oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT murakamikosaku oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT muratakoichi oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT yoshifujihajime oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT tanakamasao oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT morinobuakio oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation
AT hashimotomotomu oraldextransulfatesodiumadministrationinducesperipheralspondyloarthritisfeaturesinskgmiceaccompaniedbyintestinalbacterialtranslocationandsystemicth1andth17cellactivation